Stocktoria
Bausch & Lomb Corp BLCO
NYSE · XNYS · stock · Ophthalmic Goods · website · IPO 2022-05-06
Bausch & Lomb Corp financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $5.1B | $4.8B | $4.1B | $3.8B | $3.8B |
| SG&A expense | $2.2B | $2.1B | $1.7B | $1.5B | $1.4B |
| Operating income | $113.0M | $162.0M | $130.0M | $207.0M | $329.0M |
| Income tax | $35.0M | $71.0M | $82.0M | $58.0M | $125.0M |
| Net income | -$360.0M | -$317.0M | -$260.0M | $6.0M | $182.0M |
| EPS (diluted) | $-1.02 | $-0.90 | $-0.74 | $0.02 | $0.52 |
| Operating cash flow | $283.0M | $232.0M | -$17.0M | $345.0M | $873.0M |
| Free cash flow | -$66.0M | -$59.0M | -$198.0M | $170.0M | $680.0M |
| Cash & equivalents | $383.0M | $305.0M | $331.0M | $354.0M | $174.0M |
| Inventory | $976.0M | $1.0B | $1.0B | $628.0M | $572.0M |
| Total assets | $14.0B | $13.5B | $13.4B | $11.1B | $10.8B |
| Total liabilities | $7.5B | $6.9B | $6.5B | $4.0B | $1.4B |
| Shareholders' equity | $6.5B | $6.5B | $6.9B | $7.1B | $9.4B |
Source: SEC EDGAR filings · CIK 0001860742 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.